Table 1.
Articles on Sex-based Differences in Opioid Effects
| Author names | Year | Sample size | Article Type | Primary Outcome Measure | Drug Type | Primary Results |
|---|---|---|---|---|---|---|
| Bodnar et al. | 2003 | 6–11 rats per group (further details not reported) | Experimental | Food Intake | Morphine | Morphine-induced feeding increased in male, but not female rats at low doses, and female, but not male rats at higher doses. |
| Craft et al. | 2006 | 16–18 female rats; 16–22 male rats (numbers reported were pooled across conditions) | Experimental | Locomotor Activity | Morphine | Morphine relative to saline initially suppressed locomotor activity (an effect most pronounced in males) and later increased locomotor activity for both sexes. |
| Flores et al. | 2003 | 6 rats per each female/male group | Experimental | Distribution of opioid receptor-like 1 receptor mRNA and co-localization with estrogen receptor mRNA in neurons | N/A | ORL1 –receptor gene abundantly expressed in males/proestrus females; but significantly higher in the rostral trigeminal nucleus caudalis and the junction of the caudalis and interpolaris Vc/Vi of diestrus females |
| Francisco-DoPrado et al. | 1998 | 6 rats per each female/male group | Experimental | Hyperinsulimenia production | Naloxone and naltrexone | Pretreating concanavalin A-injected rats with naloxone or naltrexone, blocked the hyperinsulinemia produced by the lectin in males as well as females |
| Harte-Hargrove et al. | 2015 | 73 female rats; 32 male rats | Experimental | Basal transmission, long-term potentiation, mossy fiber transmission | Naloxone | Opioid antagonist naloxone enhanced mossy fiber transmission in females during proestrus, however, no effect was observed in males |
| Limonta et al. | 1991 | Minimum of 8 rats per group (further details not reported) | Experimental | MOR-Receptor density | Testosterone | Increase in the number of MOR-receptors was observed in normal females compared to the other groups of rats at day 26; also increased in males between day 26 and 60 |
| Mousavi et al. | 2007 | Saline and sham females/males (n=4 per group); Intact and gonadectomized females/males (n=8 per group) | Experimental | Glutamate levels in nucleus accumbens | Morphine | Higher glutamate levels in the nucleus accumbens of female morphine tolerant rats; overiectomy decreased the glutamate level; orchidectomy did not change glutamate levels in males |
| Osada et al. | 1991 | 23 female rats; 22 male rats | Experimental | Hippocampal neuron firing rate, responsiveness to opioid peptides | Opioid neuropeptide | Male rats higher baseline pyramidal cell firing rates than females; neurons of castrated male but not female rats were more responsive to the opioid peptide leu-enkephalin, but not dynorphin |
| Shishkina et al. | 1991 | Intact + β-endorphin females and males (n=9 per group); Gonadectomized + β-endorphin (7–8 per group) | Experimental | Gonadal hormone levels, concentration of E2 receptors | Opioid neuropeptide | β-endorphin injections did not change the concentration of estradiol receptors of female rats; reduced the level of estradiol receptors in males. Did not affect serum concentrations of testosterone or estradiol in either male or female rats. |
| Simerly | 1991 | 4 rats per each female/male group | Experimental | Proenkephalin and prodynorphin mRNA-containing neurons | Testosterone | Adult male rats expressed twice the amount of proenkephalin mRNA containing neurons in the AVPv than female mature rats at baseline. |
| Stewart & Rodaros | 1999 | 120 female rats; 48 male rats | Experimental | Locomotor activity | Morphine | Intact males (but not orchidectomized males) exhibited progressive increase in morphine-induced locomotor activity; Overiectomized estradiol treated female rats (although not without estradiol) exhibited progressive increases in morphine-induced locomotor activity |
| Van Kempen et al. | 2013 | Group 1: 24 female and male mice; Group 2: 38 female and male mice | Experimental | Dynorphin and enkephalin immunoreactivity | N/A | Females had higher levels of dynorphin immunoreactivity in CA3a and enkephalin immunoreactivity in CA3b relative to males |
| Vodo et al. | 2013 | 4 rats per each female/male group | Experimental | Estrogen receptor, androgen receptor, TRPV1 gene expression | Morphine | Morphine increased estrogen receptor α and estrogen receptor β, as well as the androgen receptor and TRPV1 mRNA expression in the ovary, but not in male teste. |
| Williams et al. | 2011 | Minimum of 4 rats per each female/male group | Experimental | Corticotropin-releasing factor, receptor immunoreactivity, density | N/A | Proestrus females expressed increased dual-labeled dendritic profiles and membrane density of corticotropin-releasing factor receptor immunoreactivity relative to males |
| Williams et al. | 2011 | Minimum of 5 rats per each female/male group | Experimental | Delta opioid receptor immunoreactivity, density | N/A | Females in proestrus (high estrogen) displayed the lowest level of delta opioid receptor immunoreactivity in the CA1 pyramidal cell layer of all groups. |